Differential expression of related molecules after acute injury of rabbits’ anterior cruciate ligament and medial collateral ligament

Objective: This study aimed to assay expression of the mRNA and proteins for injuring- and angiogenesis-associated molecules at 3 days, 1week, 2weeks, 4weeks and 6 weeks after anterior cruciate ligament or medial collateral ligament injury in male New Zealand White rabbits. Methods: Models similar to those of clinical patients were used to establish acute partial injuries of the anterior cruciate ligament and medial collateral ligament at 3 days, 1 week, 2 weeks, 4 weeks and 6 weeks and normal control groups. Molecular biological changes in male rabbits were detected at different time points after anterior cruciate ligament and medial collateral ligament injury by H&E staining, reverse transcriptase chain reaction and westren blotting. Results: Marked differences were found in the postinjury changes in gene levels and proteins in the anterior cruciate ligament compared to the medial collateral ligament. There was no increase in mRNA expression of TIMP3, TGF-βand PRG4 in the injured anterior cruciate ligament at any time point. However, the levels of these genes tended to increase in the injured medial collateral ligament. In contrast, MMP-13 mRNA levels were signicantly increased in the injured anterior cruciate ligament, but not in the medial collateral ligament. Furthermore, vascular endothelial growth factor decreased following injury to both the anterior cruciate ligament and medial collateral ligament, with the difference being a slight decrease in the medial collateral ligament and a signicant decrease in the anterior cruciate ligament. Similarly, protein blots showed higher protein expression of type I and type III collagen in the injured medial collateral ligament than in the anterior cruciate ligament. Conclusion: The results show that there were drastic differences in angiogenesis, collagen and Matrix metalloproteinases after anterior cruciate ligament and medial collateral ligament injury. It can be found that the repair ability of the anterior cruciate ligament and medial collateral ligament after injury may be related to the differences in molecular expression.


Introduction
The knee is the joint most susceptible to injury during sports activities, and the ligaments in the knee in particular can be frequently damaged [1]. In the United States alone, ligament injuries result in over 100,000 disabilities each year [2]. The two most vulnerable ligaments in the knee are the ACL (Anterior cruciate ligament) and the MCL (Medial collateral ligament). Both clinical and basic experimental studies have shown that these two kinds of ligaments have different healing potential after injuring. The MCL will repair itself after trauma [3], while ACL cannot be repaired endogenously [4]. Therefore, surgical treatment has always been the means of repairing ACL injuries. However, with the development of scienti c research, surgical treatment has been found to have many complications and disadvantages, such as postoperative osteoarthritis and secondary injury [5].
The drastic difference in healing capacity between ACL and MCL injuries is still largely unexplained.
Earlier studies believe that the differences in endogenous repair after ACL and MCL injury are mainly due to different mechanical environments [6]as well as differences in nitric oxide synthesis [7], differences in blood supply [8], and differences in the proliferative potential of broblasts [9] and differences in lysyl oxidase (LOX) expression [10]. There is a large body of evidence for differences in blood supply and differences in broblast proliferation. Bray RC [11] et al have shown that,after injury, MCL is more abundant in blood vessel volume and blood ow than ACL. Wiig [12] et al found that the expression of collagen genes in ACL broblasts was lower compared to MCL.
In recent years, with advances in molecular biology research, it has been found that a severe hypoxic environment is also a factor in the differences in endogenous repair between ACL and MCL after injury, mainly due to the adverse regulation of matrix metalloproteinases expression levels [13]. Some studies have also found that differences in self-healing ability between ACL and MCL are also related to the scaffold that the load cells and ligaments bind [14]. MCL can form scaffold after injury, but ACL cannot form a scaffold. This may be another factor affecting the endogenous repair of ACL injury.
In addition, differences in the proliferation of the two types of ligament stem cells could also explain the differences in repair capacity. Stem cells have a high differentiation capacity and are important for angiogenesis and broblast proliferation and differentiation, and play an important role in ligament repair. Zhang J [15] et al studied ACL and MCL ligament stem cells and found that MCL stem cells proliferated faster than ACL stem cells.
During ligament healing, many growth factors play an important role in repair by activating cell migration and matrix synthesis. The effect of growth factors on matrix synthesis is evident in ACL and MCL cells.
Transforming Growth Factor-β (TGF-β), Epidermal Growth Factor (EGF), Growth and Differentiation Factor 5(GDF-5) and Bone Morphogenetic Protein-7 (BMP-7) stimulate the expression of type I and type III collagen in ligamentous tissue [16][17]. Several studies have found that Nerve Growth Factor(NGF) may promote the synthesis of collagen I [18]. Therefore, studying the differences in growth factors after MCL and ACL injury is an important reference for the endogenous repair and collagen expression in ACL.
Angiogenesis is an essential step in the healing process, which helps to repair and reconstruct injured tissues.
After ligament injury, broblasts are stimulated by in ammation (cytokines and mechanical microenvironment) to obtain the "proto-myo broblast" phenotype, and then differentiate into typical myo broblasts, which are characterized by newly expressing a-Smooth muscle actin (α SMA), which is the dominant actin subtype in vascular smooth muscle cells [19]. PRG4 (proteoglycan4) is a proteoglycan 4, also known as a lubricant, with many unique biological functions, including lubrication, anti adhesion and as a regulator of cell growth [20]. Both αSMA and PRG4 play an important role in the proliferation of ligament broblasts. Collectively, these molecules are important regulators and products of cellular activity in healing tissues.
Matrix metalloproteinases are produced by various connective tissue cells, such as broblasts, endothelial cells, osteoblasts, and macrophages [21]. They have functions in tissue remodeling and repair, basement membrane degradation, tumor invasion, and neovascularization [22][23]. For example, (matrix metalloproteinases 3)MMP3 and (matrix metalloproteinases 13)MMP13 exhibit catabolic effects on collagen types I, II and III [24]. MMPs are regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs) and urinary plasminogen activator (uPA) converts brinogen into brin, an active protease involved in brinolysis and collagen degradation. Fibrin also degrades certain components of the extracellular matrix and may activate a variety of MMPs [25]. The ratio of MMPs/TIMPs usually determines the degree of extracellular matrix protein degradation and tissue remodeling, so MMPs and TIMPs series play a key role in maintaining the balance between extracellular matrix (ECM) deposition and degradation [26]. Under normal circumstances, there is a relative balance between MMPs and TIMPs in the tissue, which determines the stability of the matrix. The imbalance of MMPs and TIMPs ratio leads to the destruction of tissue structure and function and instability of joint. When the MMPs expression increases, the TIMPs expression decreases, which causes abnormal EMC degradation, leading to differences in tissue repair capabilities. Because both plasmin and MMPs have the function of degrading extracellular matrix to accommodate new blood vessels, uPA can be classi ed into substances like MMPs. After comparing the expression of different MMPs in MCL and ACL, Zhou et al [2] found that the activity of MMPs in injured ACL was higher than that in MCL. Therefore, it was concluded that many MMPs may be related to the difference in healing potential.
In addition, the difference of collagen composition between the two kinds of ligaments may also affect the self-healing ability. Collagen is the main component of ligaments, accounting for about 75% of ligament dry weight, of which type I and III collagen account for about 90% of the total collagen in the body. Type I collagen is responsible for the strength and endurance of ligament, and type III collagen is involved in ligament repair [27]. Collagen has the function of mechanical support, participates in cell attachment, migration, growth, proliferation and differentiation, and plays an important role in maintaining structural stability. Chamberlain et al [28] found that collagen synthesis increased signi cantly after ligament injury. Chun et al [29] and Murakami Het et al [30]have found that MCL broblasts in vitro can synthesize more collagen than ACL broblasts, and ACL broblasts are more likely to produce nitric oxide to induce apoptosis than MCL broblasts. Therefore, it is very important to study the difference of collagen after ACL and MCL injury to study the mechanism of endogenous repair difference between ACL and MCL.
There are relatively few descriptions about gene expression and protein expression of ligament after injury in the literature. The purpose of this study was to compare the the expression of angiogenesisrelated molecules, basement membrane degrading enzymes, inhibitors of angiogenic molecules, mRNA of matrix composition and associated protein molecules after acute ACL and MCL injury. We studied VEGF, TGF-β and NGF, three molecules associated with angiogenesis. Two matrix metalloproteinases and their inhibitors, MMP3 and MMP13, as well as TIMP-1 and TIMP-3 and the matrix metalloproteinase activator uPA. It also included αSMA and PRG4, as well as the most abundant type I and type III collagen in ligaments. This study used a model similar to that of clinical patients to examine the molecular biology of the ACL and MCL at different periods of injury, to identify factors affecting endogenous repair of the ACL, and to provide a basis for the treatment and repair of ACL injuries.

Reagents and equipments
Tissue freezing medium (OCT, SAKURA 4583) was purchased from Sakura Finetek (Torrance, California, USA), the rst antibody rabbit polyclonal antibody COL3A1 was purchased from Solarbio (Beijing, China), rabbit monoclonal antibody COL1A1/Collagen was purchased from Beyotime ( Shanghai, China),rabbit polyclonal antibody MMP1 was purchased from Beyotime (Shanghai, China) rabbit polyclonal antibody MMP13 was purchased from ABclonal (Wuhan, China) rabbit polyclonal antibody MMP3 was purchased from proteintech (Chicago, USA) and mouse monoclonal antibody β-Actin was purchased from Beyotime Medical University, and was kept normally before the experiment.

Surgery
Eighteen experimental animal rabbits were anesthetized by intravenous injection of barbital sodium (1 ml/kg,2ml;China medical university China). After the anesthesia took effect, the experimental animals were placed supine on the experimental table ,the upper limbs were cross-xed, and then the surgical area was strictly iodophor disinfected, and a disposable sterile towel was placed on the surgical area. Next the rabbits'knee joints were taken on the medial side and made an incision with a longitudinal length of about 1.5 cm. Cut the skin, bluntly separate the subcutaneous tissue and joint capsule, fully expose the ACL, ex the knee joint to 90, pierce the ACL femoral end with a 20 ml needle, and then similarly pierce the proximal third of the femoral end of the MCL, Wash the wound with normal saline, and suture the joint capsule and skin with 4 − 0 sutures. Three animals were not treated as a positive control. After the operation, all experimental animals were injected intramuscularly with the anti-infective ceftriaxone sodium for 5 days.

Tissue Samples Collection
The surgical animals were carefully raised, and the animals were euthanized by injecting air into the ear vein at 3d, 1w, 2w, 4w and 6w of the injury, and then the entire MCL and ACL of each injured leg were cut off and stored at -80℃.

Rna Extraction And Quanti cation
According to the TRIZON method, total RNA was extracted from all tissue samples. Brie y, add 1 ml/100 mg of the sample to trizon reagent, grind the tissue with a nucleic acid extractor to crush, add chloroform, then add 400-500ul of isopropanol, mix and centrifuge, and nally wash the RNA with 75% ethanol and dry at room temperature,then the Total RNA could be obtained, and it could be frozen at -80 °C or in subsequent experiments.

Determination Of Gene Levels
For each sample, 500 ng total RNA was reverse transcribed using GoScript™ Reverse Transcription System Kit (Promega). First, pre-denatured at 70 °C for 5 minutes, then annealed at 25 °C for 5 minutes, followed by extension at 42 °C for 60 minutes and at 70 °C for 15 minutes to obtain cDNA. For the cDNA of each sample, use GoTaq® qPCR Master Mix kit to amplify 1 ul of cDNA in a two-step method. The required gene primers are shown in Table 1 below. The rst is a cycle of pre-denaturation, after 120 s of pre-denaturation at 95 °C, followed by 40 cycles of ampli cation, the rst step is 95 °C ampli cation for 15 seconds, and the second step is 60 °C ampli cation for 60 seconds.

Statistical analysis
Statistical treatment was performed using Graphpad Prism 8.0 software. The all data in this study were expressed as mean ± standard deviation. One-factor analysis of variance(one-way ANOVA) was used to analyze the gene and protein levels. The ACL-injured cohort at each time point was compared with the normal ACL control, while the MCL-injured cohort at each time point was compared with the normal MCL control. Statistical signi cance was established at P < 0.05.

Histological differences after injury
The tissue changes at different time points after the injury of ACL and MCL were observed by HE staining, and it was found that ACL and MCL did not change signi cantly at each time point at the injury (Fig. 1B-1F and Fig. 1a-1f).

Expression Differences Of Related Genes
According to RT-qPCR, it was found that,compared with the control group, the partially injured ACL and MCL had signi cant differences in the expression of many related genes, and two ligaments had signi cant differences in genes expression at different time points after their injury.

MRNA Expression Of Collagen
In ACL, compared with the normal group, the expression of COL-I mRNA in the injured group was uctuating, which was statistically signi cant at 4 weeks (P < 0.05) (Fig. 2a). While the expression of type III collagen mRNA was injured After 3 days, it increased to 4 weeks and then decreased (Fig. 2b).On the contrary, in MCL, compared with the normal group, the expression of type I and type III collagen mRNA continued to increase at 3 days after injury and reached a peak at 2 weeks. The expression of type III collagen mRNA had signi cant statistical signi cance at 2 weeks (P < 0.001) (Fig. 2b), and there was also a statistical difference at 4w (P < 0.05).

MRNA Expression Of Matrix Metalloproteinases
In ACL, compared with the normal group, the expression of the matrix metalloproteinases MMP3, MMP13 and uPA mRNA increased in the injured group at 3 days after injury. The difference was that the mRNA expression of MMP3 and uPA peaked at 1week and then decreased, while the expression of MMP13 mRNA continued to rise from 1week. There was a signi cant difference between the mRNA expression of MMP3 and uPA at 1week (P < 0.001) (Fig. 3a), while the expression of MMP13 mRNA was statistically signi cant at 6weeks (P < 0.05) (Fig. 3b). On the contrary, in MCL, there was a signi cant difference with Compared with the control group in the injury group, and the mRNA expression of MMP13 and uPA did not change (Fig. 3b, 3c). However,the expression of MMP3 mRNA increased at 1week, which was statistically signi cant (P < 0.001) (Fig. 3a).

MRNA Expression Of Matrix Metalloenase Inhibitors
The mRNA expression of Matrix metalloenase inhibitors were signi cantly different in injured ACL and MCL. In ACL, compared with 3 days to 4 weeks and was statistically signi cant (P < 0.001) (Fig. 4a). But the mRNA expression of TIMP3 was decreased at 1week and 2 weeks (P < 0.05) (Fig. 4b). While there was no change in MCL compared with the control group (Fig. 4b), and the expression of TIMP3 mRNA increased at 2 weeks and 4 weeks, which was statistically signi cant (P < 0.05) (Fig. 4b).

MRNA Expression Of Angiogenesis-related Factors
According to the following histogram, compared with the control group, in ACL, the expression of TGF-β mRNA did not change at all time points (Fig. 5a), while mRNA expression of the NGF increased 3 days after injury, which was statistically signi cant at 4 weeks(P < 0.001) (Fig. 5b). The mRNA expression of VEGF began to decrease from 3days, and it was statistically signi cant at 3days and 1week (P < 0.001 ) (Fig. 5c).On the contrary, the mRNA expression for TGF-β was higher than the control group at all time points in MCL. Both have obvious statistical signi cance (P < 0.001) (Fig. 5a). The mRNA expression for NGF increased at 6weeks of injury (P < 0.05) (Fig. 5b), while The expression of VEGF mRNA expression also began to decrease at 3days, but the decrease was much lower than ACL.

Differences In Mrna Expression Of Other Related Factors
Compared with the control group, the mRNA expression of αSMA in MCL and ACL injuries both increased from 3d, and there was signi cant statistical signi cance at 3days, 1 week and 2 weeks (P < 0.001) (Fig. 6a). The difference was the expression of PRG4 mRNA, the MCL after injury continued to increase (P < 0.001) (Fig. 6b), but there was no change in ACL.

Changes in the expression of each gene at different time points of injury to ACL and MCL
According to RT-qPCR, the mRNA expression changes of 12 genes are made into the following table, and it is very intuitive to see the changing trend of different genes at different times of injury.
Notes: (↑) indicates gene expression increased as compared with ACL controls .Magnitude of change (fold-change compared to normal control) in parentheses. (↓) indicates gene expression decreased as compared with MCL controls. Magnitude of change (fold-change compared to normal control) in parentheses.

Differences In The Expression Of Related Proteins
The collagen and matrix metalloproteinases of ligaments were quantitatively analyzed by Western blot.
No matter ACL or MCL, the protein expression of collagen and matrix metalloproteinase decreased. The expression of type I and type III collagen, MMP3 and MMP13 in ACL decreased from 3 days after injury (P < 0.001) (Fig. 7), and increased slightly at 4 weeks. While in MCL, type I and type III collagen, MMP3 and MMP13 protein levels continued to decline from 3 days after injury (Fig. 7b-7e), and the expression of these four proteins in MCL was higher than that in ACL.

Discussion 1 Animal model
To further integrate clinical practice and make animal experiments and clinical cases more uniform, we improved the modeling method of the original injury. Without damaging other ligaments, we used a syringe gun head to pierce ACL and MCL (as shown in the gure below -see Animal model gure in the Supplementary Files), making the ligament tear mode close to the ligament injury mode of patients, and provide more reference for clinical diagnosis and treatment.

Results
ACL plays an important role in controlling and stabilizing the knee joints, but it has a poor healing capacity. Molecular differences between the ACL and the MCL help to explain their different healing abilities. However, the process of injury and repair of the ACL and MCL is very complex. Therefore, we need to study the differences in different ways. Previous studies of ACL injury mainly have focused on ACL reconstruction. Here, we study the molecular biological differences at the time of injury.
In this study, we conducted a comparative study of molecules associated with the ACL and MCL at different times after injury. Comparative studies were conducted in terms of the collagen composition of the ligament, matrix metalloproteinases, and their inhibitors, and angiogenesis-related molecules to nd the molecular causes of the differences in the healing ability of ACL and MCL injuries. We mainly focused on MMP3 and MMP13. Because they are key players in the various stages healing process, these stages can eliminate damaged proteins, disrupt the temporary ECM, possibly control angiogenesis and regulate the activity of certain growth factors [31].
In the injured ACL, the mRNA expression level of MMP3 increased to 1w for the rst time after injury, but the expression of MMP13 continued to increase after injury. The expression of matrix metalloproteinase activator uPA followed the same trend as the expression of MMP3. Differently,in MCL injured tissue, MMP13 mRNA expression was lower compared with the MCL control at multiple time points after injure, in contrast to after ACL. MMP13 tended to decrease after MCL injury, indicating that its ability to degrade extracellular matrix and collagen was weaker than injured ACL which facilitated the formation of scar tissue and repair of injured ligaments. The differential expression of matrix metalloproteinases between injured ACL and MCL may be related to the location of the ligaments. The ACL is located within the joint capsule. After the injury, ACL is exposed to a synovial uid containing in ammatory substances that inhibit healing [32]. Previous studies have also reported a signi cant increase for MMP13 mRNA expression in cartilage and synovium following ACL injury [33]. Several researchers have also observed a similar sustained upward trend in the gene for MMP13 in injured sheep ACLs [34]. Tang et al. reported increased mRNA expression of MMP13 in ACL during the acute phase of ACL injury [33].
In normal tissues, the stoichiometric ratio of MMP13/TIMP1 is 1:1 [35]. However, we found that the ratio of MMP-13/TIMP-1 in the injured ACL uctuated considerably after injury but stabilized at the MCL, indicating that the stability of MMP-13/TIMP-1 was destabilized after injury, which may be an in uential factor in the di culty of self-healing of the ACL. Therefore, inhibition of MMP13 expression in ligaments is considered to be an important factor in promoting ligament tissue repair.
We also did quantitative analysis of protein expression of MMP3 and MMP13 by Western blot. In our experiments, we found inconsistencies between the mRNA expression and protein expression of MMP3 and MMP13, and we considered that some other non-coding RNAs might be involved in the transcriptional regulation of MMP3 and MMP13 proteins. The non-coding regulation of MMP3 and MMP13 protein expression has been studied by others. miR-134 was found to regulate MMP3 expression by Chen [36]. Similarly, Seidl CI et al [37] found that miR-675 could regulate MMP13 expression, but it has also been found that miR-411 could also regulate MMP13 expression by expression to regulate tissue repair [38].
Collagen is the most abundant substance in ligaments, so differences in ligament composition can be analyzed by estimating the expression of these collagens. In normal tissues, type I and type III collagen remain in a physiologically stable ratio, however, when ligaments are injured and collagen metabolism is disturbed due to impaired cell proliferation and biosynthesis, the amount of type I collagen decreases, and the amount and ratio of type III collagen increases and decreases. The disruption of collagen metabolism is associated with the mechanical properties of the connective tissue.
Our study found that in the injured ACL and MCL, the mRNA expression of type I and type III collagen were different. In MCL tissues, type I and type III collagen gradually increased from 3 days after injury and peaked at 2 weeks, and the trends of both collagen types were generally consistent. In contrast, in ACL tissue, the mRNA expression of type I collagen uctuated at different times after ACL injury, whereas the mRNA expression of type III collagen gradually increased after injury, reaching a maximum at 4 weeks, with a different trend from the mRNA expression of these two collagens in MCL.
One investigator found increased collagenase activity and decreased total collagen in the damaged ACL, which is generally consistent with our ndings. Similarly, it has been found that collagen mRNA levels of the injured MCL were higher than that of the ACL at all postoperative time intervals. This suggests that collagen mRNA levels are higher in MCL tissue than in ACL tissue in both normal and injured states [39], which is supported by protein blotting studies of collagen expression. In addition, numerous in vitro studies have shown that natural broblasts from these tissues have intrinsically different abilities to proliferate, migrate and produce matrix 15 . The ACL and MCL exhibit completely different healing processes following injury. The injured MCL heals easily and forms a visible scars [40], whereas the injured ACL never heals. The amount of scar tissue formed in the ligament after ACL injury is reduced due to the reduced structural protein synthesis potential after injury.
In this study, the gene expression of NGF and VEGF was found to change considerably after an ACL injury but stabilized at the MCL. The gene expression of NGF gradually increased after an ACL injury, indicating an abundant distribution of nerves within the ACL. Our previous study also found that there are more mechanoreceptors to transmit nerve signals in the ACL than in the MCL [41]. TGF-β is an important growth factor for broblasts and myo broblasts and is one of the most important promoters of scar formation [42]. In our study, TGF-β gene expression was reduced after ACL injury but increased in the injured MCL, which correlated with the healing ability of both.
TGF-β can induce angiogenesis by directly stimulating cytokines involved in endothelial growth and by promoting the surrounding environment. TGF-β may play an important role in promoting ligament repair and remodeling. Gene expression of vascular endothelial growth factor increased and peaked 3 days after ACL injury and then continued to decline with an increased decline; however, in the injured MCL, VEGF expression gradually decreased but increased at 6weeks after injury. Based on the trends in VEGF gene expression in the ACL and MCL before the injury, expression was relatively stable after injury in the MCL, suggesting that the MCL is richly vascularised but the ACL is different. The upper third of the injury is the most abundant location in the anterior cruciate ligament and is less vascular, severely compromising blood supply and neovascularization. In a recent study, Bray et al. found that the MCL has a good blood supply, which may be an in uential factor in its strong self-healing ability [10].
Besides, we also studied αSMA and PRG4 and found that the mRNA expression of αSMA increased gradually after ACL and MCL injury, but the difference was that the increase was more pronounced in injured MCL and the change in TGF-β was more pronounced than in ACL. This suggests that vascular smooth muscle is more active after MCL injury than ACL, vascularity is more abundant in MCL broblasts. Meanwhile, several studies have found that in both intact and damaged human ACL, myo broblasts play an important role in the systolic phase of ligament healing, allowing them to regain their original length [43][44].
In ACL and MCL, we found that the expression of PRG4 began to decrease at 3 days after injury. The difference was that the trend of change after injury was less pronounced in ACL, which was lower than the normal group but gradually increased in MCL, exceeding the level of the normal group at 6 weeks after injury, indicating that MCL had more active cell growth factors and also suggesting a more pronounced anti-in ammatory effect after injury in MCL than in ACL. Some animal studies have also found that PRG4 concentrations in ACL begin to decline at three weeks post-injury and only return to normal values within one-year post-injury [45][46].
From our research, we believe that differences in ligament healing ability may be due to several factors.
The ACL is an extracellular structure surrounded by a thin layer of synovial tissue in the intra-articular environment and is therefore exposed to synovial uid, hemorrhagic breakdown products and proteolytic enzymes when synovial tissue is ruptured [47]. Due to its extra-articular location and very limited vascular bed environment, the ACL is unable to form intermediate scar tissue and lacks an initial in ammatory response, resulting in a lack of good self-healing ability.
By studying mRNA for collagen, matrix metalloproteinases and their inhibitors, and angiogenesis-related factors, molecular differences between the ACL and MCL following injury were identi ed and validated from several speci c proteins. We provide a direction and basis for the study of endogenous repair of the ACL, but our experiments still have some limitations. The protein expression studied was not comprehensive enough to were interfered with by other factors in the regulation of protein expression. Identifying these interfering factors may more accurately explain the differences in repair between injured ACL and injured MCL, which is the direction of our subsequent work.

Page 15/19
The results show that there were a signi cant difference between ACL and MCL in terms of vascular renewal, collagen and matrix metalloproteinases after injury, with MCL showing lower changes in matrix metalloenzymes and higher vascular renewal than ACL, indicating that MCL is more stable after injury and has a higher self-healing and anti-in ammatory capacity than ACL. The expression of PRG4 and αSMA were both higher in MCL than in ACL, indicating that the former was stronger than the latter in terms of broblast viability and cytokine activity after ligament injury. Therefore, it can be found that the repair ability of ACL and MCL after injury is related to the difference in molecular expression.

Declarations
Funding This study was supported by Natural Science Foundation Guidance Program Project of Liaoning Province NO. 20180550251.
Compliance with ethical standards Con icts of interest The authors afrm that they have no con ct of interest.
Availability of data and material All data generated or analysed during this study are included in this published article.